Biolase, Inc. (BIOL) financial statements (2020 and earlier)

Company profile

Business Address 4 CROMWELL
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3843 - Dental Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6812912321
Cash and cash equivalents6812912321
Restricted cash and investments00000  
Receivables91110109911
Inventory, net of allowances, customer advances and progress billings11121214131311
Inventory11121214131311
Prepaid expense and other current assets2
Other undisclosed current assets122212 
Total current assets:27333634355526
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment1244412
Intangible assets, net (including goodwill)3333333
Goodwill3333333
Intangible assets, net (excluding goodwill)    000
Other noncurrent assets000110 
Prepaid expense and other noncurrent assets0
Total noncurrent assets:5578755
TOTAL ASSETS:32394342425931
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10131115121616
Accounts payable5659689
Accrued liabilities5866655
Employee-related liabilities     22
Taxes payable     00
Deferred revenue2
Debt13     5
Deferred revenue and credits33323
Customer advances and deposits0000
Contract with customer, liability2
Other undisclosed current liabilities     (2)(2)
Total current liabilities:26161318151622
Noncurrent Liabilities
Long-term debt and lease obligation011  0  
Long-term debt, excluding current maturities 11     
Capital lease obligations   0  
Operating lease, liability0
Liabilities, other than long-term debt2101111
Deferred revenue and credits000 0
Accounts payable and accrued liabilities000111 
Deferred revenue0
Deferred tax liabilities, net    11
Other liabilities10000  
Other undisclosed noncurrent liabilities00011  
Total noncurrent liabilities:21102211
Total liabilities:28271420171723
Temporary equity, carrying amount4      
Stockholders' equity
Stockholders' equity attributable to parent011292225428
Common stock0000000
Treasury stock, value      (16)
Additional paid in capital236228225201189185149
Accumulated other comprehensive loss(1)(1)(1)(1)(1)(1)(0)
Accumulated deficit(235)(217)(195)(178)(163)(143)(124)
Total stockholders' equity:011292225428
TOTAL LIABILITIES AND EQUITY:32394342425931

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues38464752484856
Revenue, net4752484856
Cost of revenue(24)(29)(32)(32)(33)(29)(36)
Cost of goods and services sold(0)(0)(1)(0)(1)(1)(36)
Other undisclosed gross profit      1
Gross profit:14171520161822
Operating expenses(30)(38)(33)(35)(36)(36)(33)
Operating loss:(16)(21)(18)(15)(20)(18)(11)
Nonoperating income (expense)(2)(1)1(0)(0)(1)(1)
Foreign currency transaction gain (loss), before tax(0)(0)1(0)(0)(0)(0)
Interest and debt expense(0)(0)   (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes     00
Loss from continuing operations before equity method investments, income taxes:(18)(22)(17)(15)(20)(19)(12)
Other undisclosed income from continuing operations before income taxes00     
Loss from continuing operations before income taxes:(18)(21)(17)(15)(20)(19)(12)
Income tax expense (benefit)0(0)1(0)(0)(0)0
Net loss attributable to parent:(18)(22)(17)(15)(20)(19)(11)
Preferred stock dividends and other adjustments  (4)(2)   
Net loss available to common stockholders, diluted:(18)(22)(21)(18)(20)(19)(11)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(18)(22)(17)(15)(20)(19)(11)
Comprehensive loss:(18)(22)(17)(15)(20)(19)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0(0)(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(18)(22)(17)(15)(21)(19)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: